Mentions
Extended reach
Total likes
Video views
AI synopsis
These discussions highlight the promising results of the study, with comments like 'significantly reduced BP' and references to the 'MODERATO II controlled study,' indicating interest in innovative treatment options. The tone remains positive yet measured, emphasizing the potential of pacemaker-based cardiac neuromodulation without overly optimistic claims, reflecting moderate engagement and perceived impact.
Most discussions acknowledge the positive findings of the study, mentioning the significant BP reductions observed in the research.
The mentions demonstrate moderate curiosity, focusing on the potential clinical implications without delving into technical details.
Participants show some engagement by referencing specific study outcomes and commentaries, but their involvement remains relatively surface-level.
There is a recognition that the findings could influence future hypertension treatments, although the discussions remain cautious and exploratory.
Backbeat CNT significantly reduced BP in a MODERATO II randomized controlled study of hypertensive pacemaker patients. https://t.co/oZ3rpZO3u6 @BurkhoffMD @OrchestraBioMed #AHAJournals https://t.co/HPrV4urBcz
This week in cardiology, Dr. John Mandrola discusses AI and ECG advances, novel hypertension treatments using pacemakers, and procedural issues in AF ablation. The study shows pacemaker-based neuromodulation can…
This study explores the effects of cardiac neuromodulation therapy using the Moderato pacemaker, which significantly reduced systolic blood pressure over 6 months in hypertensive patients, offering a promising…
This episode explores how pacemaker-based cardiac neuromodulation, targeting the heart's role in blood pressure regulation, can significantly reduce hypertension symptoms, offering a promising new treatment approach.
Backbeat CNT significantly reduced BP in a MODERATO II randomized controlled study of hypertensive pacemaker patients. https://t.co/oZ3rpZO3u6 @BurkhoffMD @OrchestraBioMed #AHAJournals https://t.co/HPrV4urBcz